Article info
PDFColon
Original article
MED12 is recurrently mutated in Middle Eastern colorectal cancer
- Correspondence to Dr Khawla S Al-Kuraya, Human Cancer Genomic Research, King Faisal Specialist Hospital and Research Centre, Research Centre at KFNCCC, MBC#98-16, P.O. Box 3354, Riyadh 11211, Saudi Arabia; kkuraya{at}kfshrc.edu.sa
Citation
MED12 is recurrently mutated in Middle Eastern colorectal cancer
Publication history
- Received October 31, 2016
- Revised January 5, 2017
- Accepted January 12, 2017
- First published February 9, 2017.
Online issue publication
July 25, 2018
Article Versions
- Previous version (25 July 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/